A Pilot Study of Active Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 29 Jun 2017
At a glance
- Drugs AVX 701 (Primary)
- Indications Colon cancer
- Focus Adverse reactions
- 25 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 05 Aug 2016 Planned End Date changed from 1 Nov 2017 to 1 Nov 2018.
- 11 Jan 2014 Planned End Date changed from 1 Aug 2017 to 1 Nov 2017 as reported by ClinicalTrials.gov record.